Back to Journals » Drug Design, Development and Therapy » Volume 17
Original Research
Efficacy and Prognostic Factors of Regorafenib in the Treatment of BCLC Stage C Hepatocellular Carcinoma After Failure of the First-Line Therapy
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
3,470 | Dovepress* | 3,276+ | 80 | 3,356 | |
PubMed Central* | 194 | 90 | 284 | ||
Totals | 3,470 | 170 | 3,640 | ||
*Since 16 February 2023 |
View citations on PubMed Central and Google Scholar